• 1. Ester-mediated peptide formation promoted by deep eutectic solvents: a facile pathway to proto-peptides?
  Chen-Yu Chien,Sheng-Sheng Yu Chem. Commun., 2020,56, 11949-11952
• 2. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
• 3. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 4. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 5. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

Introduction to (1S,5R)-6-azabicyclo[3.2.1]octane-5-carboxylic Acid (CAS No. 882214-26-8)

(1S,5R-6-azabicyclo[3.2.1]octane-5-carboxylic acid) is a highly specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal biology due to its unique structural and functional properties. This compound, identified by its CAS number 882214-26-8, belongs to a class of molecules known for their potential in drug discovery and development. The intricate bicyclic structure, combined with the presence of an azabicyclo framework, makes this compound a subject of intense research interest.

The stereochemistry of (1S,5R-6-azabicyclo[3.2.1]octane-5-carboxylic acid) is crucial to its biological activity, with the specific arrangement of substituents at the 1S and 5R positions influencing its interactions with biological targets. This stereochemical configuration has been carefully optimized through advanced synthetic methodologies, ensuring that the compound exhibits high selectivity and efficacy in biological systems.

In recent years, there has been a growing emphasis on the development of novel scaffolds that can serve as starting points for the discovery of new therapeutic agents. The bicyclic structure of (1S,5R-6-azabicyclo[3.2.1]octane-5-carboxylic acid) provides a versatile platform for further derivatization, allowing researchers to explore a wide range of biological activities. This flexibility has made it an attractive candidate for medicinal chemists looking to develop drugs targeting various diseases.

The synthesis of (1S,5R-6-azabicyclo[3.2.1]octane-5-carboxylic acid) involves complex organic transformations that require precise control over reaction conditions and stereochemistry. Advanced techniques such as asymmetric catalysis and chiral resolution have been employed to achieve the desired stereoisomer with high enantiomeric purity. These synthetic strategies not only highlight the sophistication of modern chemical synthesis but also underscore the importance of precision in constructing biologically active molecules.

One of the most compelling aspects of (1S,5R-6-azabicyclo[3.2.1]octane-5-carboxylic acid) is its potential as a lead compound in drug discovery. Preliminary studies have demonstrated that this compound exhibits promising pharmacological properties, including interaction with specific enzymes and receptors relevant to human health and disease. These interactions are being further investigated to understand the mechanisms by which this compound might modulate biological pathways.

The role of computational chemistry and molecular modeling in studying (1S,5R-6-azabicyclo[3.2.1]octane-5-carboxylic acid) cannot be overstated. By leveraging computational tools, researchers can predict how this compound might interact with biological targets at the molecular level. This approach not only accelerates the drug discovery process but also provides valuable insights into the structure-activity relationships that govern its biological behavior.

In conclusion, (1S,5R-6-azabicyclo[3.2.1]octane-5-carboxylic acid) represents a significant advancement in the field of pharmaceutical chemistry. Its unique structural features and promising biological activities make it a valuable asset in the quest for new therapeutic agents. As research continues to uncover new applications for this compound, it is likely to play an increasingly important role in the development of innovative treatments for various diseases.

• 781676-26-4(Cycloprop[b]indole-1a(1H)-carboxylicacid, octahydro-, (1aS,2aS,6aS,6bS)-)
• 73550-56-8(2-Azabicyclo[2.1.1]hexane-1-carboxylic acid)
• 794499-96-0((2S)-2-Methyloctahydro-1H-indole-2-carboxylic acid)
• 939760-85-7(1-ISOBUTYLAMINO-CYCLOHEXANECARBOXYLIC ACID HYDROCHLORIDE)
• 182137-43-5(7-azabicyclo[2.2.1]heptane-1-carboxylic acid hydrochloride)
• 331258-38-9(7-Azabicyclo[2.2.1]heptane-1-carboxylic acid)
• 63399-77-9((2R)-2-methylpyrrolidine-2-carboxylic acid)
• 637020-45-2(2-Propylproline hydrochloride)
• 882182-42-5((1R,5S)-6-azabicyclo[3.2.1]octane-5-carboxylic acid hydrochloride)
• 882182-41-4((1S,5R)-6-azabicyclo[3.2.1]octane-5-carboxylic acid hydrochloride)